1.Screening
1.1.Management for Progress
1.2.Inclusion Criteria
|
dignosis of prostate cancer by biopsy | |
|
age |
|
1.3.Exclusion Criteria
2.Baseline
- Management for Progress(B)
- General information
- Physical examination
- Blood Routine Tests
- Urine and Stool Routine Tests
- Blood Electrolytes Tests
- Coagulation Function Tests
- Serum Liver Function Tests
- HBV Markers Test
- Renel Function Test
- Heat Function Examination
- Image Examinations
- Blood Gas Analysis
- Health Relative Quality of Life
- TPSA
- FPSA
- TPSA/FPSA
2.1.Management for Progress(B)
2.2.General information
2.3.Physical examination
2.4.Blood Routine Tests
2.5.Urine and Stool Routine Tests
2.6.Blood Electrolytes Tests
2.7.Coagulation Function Tests
2.8.Serum Liver Function Tests
2.9.HBV Markers Test
2.10.Renel Function Test
2.11.Heat Function Examination
2.12.Image Examinations
2.13.Blood Gas Analysis
2.14.Health Relative Quality of Life
2.15.TPSA
|
2.16.FPSA
2.17.TPSA/FPSA
4.At the end of the treatment
- Management for Progress
- Physical examination
- Blood Routine Tests
- Urine and Stool Routine Tests
- Serum Electrolytes Tests
- Liver Function Tests
- HBV Markers Test
- Renel Function Test
- Heat Function Examination
- Image Examinations
- Blood Gas Analysis
- Health Relative Quality of Life
4.1.Management for Progress
4.2.Physical examination
4.3.Blood Routine Tests
4.4.Urine and Stool Routine Tests
4.5.Serum Electrolytes Tests
4.6.Liver Function Tests
4.7.HBV Markers Test
4.8.Renel Function Test
4.9.Heat Function Examination
4.10.Image Examinations
4.14.Blood Gas Analysis
4.16.Health Relative Quality of Life
6.Follow-up 2
7.Follow-up 3